mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.04 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.04 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.05 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.05 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |